APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meperidine (Demerol)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Meperidine (Demerol) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchMeperidine (Demerol) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Meperidine (Demerol) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Meperidine (Demerol) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meperidine (Demerol) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Meperidine (Demerol) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Meperidine (Demerol) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meperidine (Demerol) include Actavis Plc, Boehringer Ingelheim, Egalet, Endo Pharmaceuticals Inc, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, Sun Pharmaceutical Industries Ltd and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meperidine (Demerol) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meperidine (Demerol) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meperidine (Demerol) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meperidine (Demerol) market size, projected growth trends, production technologies, key applications, and end-use industries.

Meperidine (Demerol) Segment by Company

Actavis Plc

Boehringer Ingelheim

Egalet

Endo Pharmaceuticals Inc

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

Sun Pharmaceutical Industries Ltd

Pfizer Inc

Sanofi

Meperidine (Demerol) Segment by Type

Powder

Liquid

Meperidine (Demerol) Segment by Application

Anesthesia

Cough Suppressant

Diarrhea suppressant

Meperidine (Demerol) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meperidine (Demerol) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meperidine (Demerol) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meperidine (Demerol).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meperidine (Demerol) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meperidine (Demerol) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Meperidine (Demerol) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Meperidine (Demerol) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Meperidine (Demerol) Industry Trends Table 2. Meperidine (Demerol) Industry Drivers Table 3. Meperidine (Demerol) Industry Opportunities and Challenges Table 4. Meperidine (Demerol) Industry Restraints Table 5. Global Meperidine (Demerol) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Meperidine (Demerol) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Meperidine (Demerol) Sales by Manufacturers (mg) & (2021-2026) Table 8. Global Meperidine (Demerol) Sales Market Share by Manufacturers Table 9. Global Meperidine (Demerol) Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Meperidine (Demerol) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Meperidine (Demerol) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Meperidine (Demerol) Manufacturers, Product Type & Application Table 13. Global Meperidine (Demerol) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Meperidine (Demerol) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Liquid Table 18. Global Meperidine (Demerol) Sales by Type 2021 VS 2025 VS 2032 (mg) Table 19. Global Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 20. Global Meperidine (Demerol) Sales by Type (2027-2032) & (mg) Table 21. Global Meperidine (Demerol) Sales Market Share by Type (2021-2026) Table 22. Global Meperidine (Demerol) Sales Market Share by Type (2027-2032) Table 23. Global Meperidine (Demerol) Revenue by Type 2021 VS 2025 VS 2032 (mg) Table 24. Global Meperidine (Demerol) Revenue by Type (2021-2026) & (mg) Table 25. Global Meperidine (Demerol) Revenue by Type (2027-2032) & (mg) Table 26. Global Meperidine (Demerol) Revenue Market Share by Type (2021-2026) Table 27. Global Meperidine (Demerol) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Anesthesia Table 29. Major Manufacturers of Cough Suppressant Table 30. Major Manufacturers of Diarrhea suppressant Table 31. Global Meperidine (Demerol) Sales by Application 2021 VS 2025 VS 2032 (mg) Table 32. Global Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 33. Global Meperidine (Demerol) Sales by Application (2027-2032) & (mg) Table 34. Global Meperidine (Demerol) Sales Market Share by Application (2021-2026) Table 35. Global Meperidine (Demerol) Sales Market Share by Application (2027-2032) Table 36. Global Meperidine (Demerol) Revenue by Application 2021 VS 2025 VS 2032 (mg) Table 37. Global Meperidine (Demerol) Revenue by Application (2021-2026) & (mg) Table 38. Global Meperidine (Demerol) Revenue by Application (2027-2032) & (mg) Table 39. Global Meperidine (Demerol) Revenue Market Share by Application (2021-2026) Table 40. Global Meperidine (Demerol) Revenue Market Share by Application (2027-2032) Table 41. Global Meperidine (Demerol) Sales by Region: 2021 VS 2025 VS 2032 (mg) Table 42. Global Meperidine (Demerol) Sales by Region (2021-2026) & (mg) Table 43. Global Meperidine (Demerol) Sales Market Share by Region (2021-2026) Table 44. Global Meperidine (Demerol) Sales Forecasted by Region (2027-2032) & (mg) Table 45. Global Meperidine (Demerol) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 47. North America Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 48. North America Meperidine (Demerol) Sales by Country (2027-2032) & (mg) Table 49. Europe Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 50. Europe Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 51. Europe Meperidine (Demerol) Sales by Country (2027-2032) & (mg) Table 52. Asia Pacific Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 53. Asia Pacific Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 54. Asia Pacific Meperidine (Demerol) Sales by Country (2027-2032) & (mg) Table 55. South America, Middle East and Africa Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 56. South America, Middle East and Africa Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 57. South America, Middle East and Africa Meperidine (Demerol) Sales by Country (2027-2032) & (mg) Table 58. Global Meperidine (Demerol) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Meperidine (Demerol) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Meperidine (Demerol) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Meperidine (Demerol) Revenue Market Share by Region (2021-2026) Table 62. Global Meperidine (Demerol) Revenue Market Share by Region (2027-2032) Table 63. Actavis Plc Company Information Table 64. Actavis Plc Business Overview Table 65. Actavis Plc Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Actavis Plc Meperidine (Demerol) Product Portfolio Table 67. Actavis Plc Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Meperidine (Demerol) Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Egalet Company Information Table 74. Egalet Business Overview Table 75. Egalet Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Egalet Meperidine (Demerol) Product Portfolio Table 77. Egalet Recent Development Table 78. Endo Pharmaceuticals Inc Company Information Table 79. Endo Pharmaceuticals Inc Business Overview Table 80. Endo Pharmaceuticals Inc Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio Table 82. Endo Pharmaceuticals Inc Recent Development Table 83. Janssen Pharmaceuticals Company Information Table 84. Janssen Pharmaceuticals Business Overview Table 85. Janssen Pharmaceuticals Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio Table 87. Janssen Pharmaceuticals Recent Development Table 88. Mallinckrodt Pharmaceuticals Company Information Table 89. Mallinckrodt Pharmaceuticals Business Overview Table 90. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio Table 92. Mallinckrodt Pharmaceuticals Recent Development Table 93. Purdue Pharma Company Information Table 94. Purdue Pharma Business Overview Table 95. Purdue Pharma Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Purdue Pharma Meperidine (Demerol) Product Portfolio Table 97. Purdue Pharma Recent Development Table 98. Sun Pharmaceutical Industries Ltd Company Information Table 99. Sun Pharmaceutical Industries Ltd Business Overview Table 100. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio Table 102. Sun Pharmaceutical Industries Ltd Recent Development Table 103. Pfizer Inc Company Information Table 104. Pfizer Inc Business Overview Table 105. Pfizer Inc Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer Inc Meperidine (Demerol) Product Portfolio Table 107. Pfizer Inc Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Meperidine (Demerol) Sales (mg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi Meperidine (Demerol) Product Portfolio Table 112. Sanofi Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Meperidine (Demerol) Distributors List Table 116. Meperidine (Demerol) Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Meperidine (Demerol) Product Image Figure 2. Global Meperidine (Demerol) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meperidine (Demerol) Market Size (2021-2032) & (US$ Million) Figure 4. Global Meperidine (Demerol) Sales (2021-2032) & (mg) Figure 5. Global Meperidine (Demerol) Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Meperidine (Demerol) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Liquid Image Figure 10. Global Meperidine (Demerol) Sales by Type (2021 VS 2025 VS 2032) & (mg) Figure 11. Global Meperidine (Demerol) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Meperidine (Demerol) Sales Market Share by Type (2021-2032) Figure 13. Global Meperidine (Demerol) Revenue by Type (2021 VS 2025 VS 2032) & (mg) Figure 14. Global Meperidine (Demerol) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Meperidine (Demerol) Revenue Market Share by Type (2021-2032) Figure 16. Anesthesia Image Figure 17. Cough Suppressant Image Figure 18. Diarrhea suppressant Image Figure 19. Global Meperidine (Demerol) Sales by Application (2021 VS 2025 VS 2032) & (mg) Figure 20. Global Meperidine (Demerol) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Meperidine (Demerol) Sales Market Share by Application (2021-2032) Figure 22. Global Meperidine (Demerol) Revenue by Application (2021 VS 2025 VS 2032) & (mg) Figure 23. Global Meperidine (Demerol) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Meperidine (Demerol) Revenue Market Share by Application (2021-2032) Figure 25. North America Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 26. North America Meperidine (Demerol) Sales Market Share by Country (2021-2032) Figure 27. U.S. Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 28. Canada Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 29. Mexico Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 30. Europe Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 31. Europe Meperidine (Demerol) Sales Market Share by Country (2021-2032) Figure 32. Germany Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 33. France Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 34. U.K. Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 35. Italy Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 36. Netherlands Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 37. Asia Pacific Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 38. Asia Pacific Meperidine (Demerol) Sales Market Share by Country (2021-2032) Figure 39. China Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 40. Japan Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 41. South Korea Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 42. Southeast Asia Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 43. India Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 44. Australia Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 45. South America, Middle East and Africa Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 46. South America, Middle East and Africa Meperidine (Demerol) Sales Market Share by Country (2021-2032) Figure 47. Brazil Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 48. South Africa Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 49. Saudi Arabia Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 50. Turkey Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 51. Argentina Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 52. UAE Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 53. Egypt Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 54. Chile Meperidine (Demerol) Sales and Growth Rate (2021-2032) & (mg) Figure 55. Global Meperidine (Demerol) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Meperidine (Demerol) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Meperidine (Demerol) Revenue (2021-2032) & (US$ Million) Figure 58. North America Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Meperidine (Demerol) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Meperidine (Demerol) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Meperidine (Demerol) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Meperidine (Demerol) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Meperidine (Demerol) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Anesthesia
  • Cough Suppressant
  • Diarrhea suppressant
Companies covered
  • Actavis Plc
  • Boehringer Ingelheim
  • Egalet
  • Endo Pharmaceuticals Inc
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • Sun Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Meperidine (Demerol) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Meperidine (Demerol) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Meperidine (Demerol) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Meperidine (Demerol) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Meperidine (Demerol) Market Dynamics
  1. 2.1 Meperidine (Demerol) Industry Trends
  2. 2.2 Meperidine (Demerol) Industry Drivers
  3. 2.3 Meperidine (Demerol) Industry Opportunities and Challenges
  4. 2.4 Meperidine (Demerol) Industry Restraints
3 Meperidine (Demerol) Market by Manufacturers
  1. 3.1 Global Meperidine (Demerol) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Meperidine (Demerol) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Meperidine (Demerol) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Meperidine (Demerol) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meperidine (Demerol) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Meperidine (Demerol) Manufacturers, Product Type & Application
  7. 3.7 Global Meperidine (Demerol) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meperidine (Demerol) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meperidine (Demerol) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meperidine (Demerol) Tier 1, Tier 2, and Tier 3
4 Meperidine (Demerol) Market by Type
  1. 4.1 Meperidine (Demerol) Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Liquid
  4. 4.2 Global Meperidine (Demerol) Sales by Type
  5. 4.2.1 Global Meperidine (Demerol) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Meperidine (Demerol) Sales by Type (2021-2032)
  7. 4.2.3 Global Meperidine (Demerol) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Meperidine (Demerol) Revenue by Type
  9. 4.3.1 Global Meperidine (Demerol) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Meperidine (Demerol) Revenue by Type (2021-2032)
  11. 4.3.3 Global Meperidine (Demerol) Revenue Market Share by Type (2021-2032)
5 Meperidine (Demerol) Market by Application
  1. 5.1 Meperidine (Demerol) Application Introduction
  2. 5.1.1 Anesthesia
  3. 5.1.2 Cough Suppressant
  4. 5.1.3 Diarrhea suppressant
  5. 5.2 Global Meperidine (Demerol) Sales by Application
  6. 5.2.1 Global Meperidine (Demerol) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meperidine (Demerol) Sales by Application (2021-2032)
  8. 5.2.3 Global Meperidine (Demerol) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Meperidine (Demerol) Revenue by Application
  10. 5.3.1 Global Meperidine (Demerol) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Meperidine (Demerol) Revenue by Application (2021-2032)
  12. 5.3.3 Global Meperidine (Demerol) Revenue Market Share by Application (2021-2032)
6 Global Meperidine (Demerol) Sales by Region
  1. 6.1 Global Meperidine (Demerol) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meperidine (Demerol) Sales by Region (2021-2032)
  3. 6.2.1 Global Meperidine (Demerol) Sales by Region (2021-2026)
  4. 6.2.2 Global Meperidine (Demerol) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Meperidine (Demerol) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Meperidine (Demerol) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Meperidine (Demerol) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Meperidine (Demerol) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Meperidine (Demerol) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Meperidine (Demerol) Revenue by Region
  1. 7.1 Global Meperidine (Demerol) Revenue by Region
  2. 7.1.1 Global Meperidine (Demerol) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Meperidine (Demerol) Revenue by Region (2021-2026)
  4. 7.1.3 Global Meperidine (Demerol) Revenue by Region (2027-2032)
  5. 7.1.4 Global Meperidine (Demerol) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Meperidine (Demerol) Revenue (2021-2032)
  8. 7.2.2 North America Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Meperidine (Demerol) Revenue (2021-2032)
  11. 7.3.2 Europe Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Meperidine (Demerol) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Meperidine (Demerol) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Meperidine (Demerol) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis Plc
  2. 8.1.1 Actavis Plc Company Information
  3. 8.1.2 Actavis Plc Business Overview
  4. 8.1.3 Actavis Plc Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Plc Meperidine (Demerol) Product Portfolio
  6. 8.1.5 Actavis Plc Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Meperidine (Demerol) Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Egalet
  14. 8.3.1 Egalet Company Information
  15. 8.3.2 Egalet Business Overview
  16. 8.3.3 Egalet Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Egalet Meperidine (Demerol) Product Portfolio
  18. 8.3.5 Egalet Recent Developments
  19. 8.4 Endo Pharmaceuticals Inc
  20. 8.4.1 Endo Pharmaceuticals Inc Company Information
  21. 8.4.2 Endo Pharmaceuticals Inc Business Overview
  22. 8.4.3 Endo Pharmaceuticals Inc Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio
  24. 8.4.5 Endo Pharmaceuticals Inc Recent Developments
  25. 8.5 Janssen Pharmaceuticals
  26. 8.5.1 Janssen Pharmaceuticals Company Information
  27. 8.5.2 Janssen Pharmaceuticals Business Overview
  28. 8.5.3 Janssen Pharmaceuticals Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio
  30. 8.5.5 Janssen Pharmaceuticals Recent Developments
  31. 8.6 Mallinckrodt Pharmaceuticals
  32. 8.6.1 Mallinckrodt Pharmaceuticals Company Information
  33. 8.6.2 Mallinckrodt Pharmaceuticals Business Overview
  34. 8.6.3 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio
  36. 8.6.5 Mallinckrodt Pharmaceuticals Recent Developments
  37. 8.7 Purdue Pharma
  38. 8.7.1 Purdue Pharma Company Information
  39. 8.7.2 Purdue Pharma Business Overview
  40. 8.7.3 Purdue Pharma Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma Meperidine (Demerol) Product Portfolio
  42. 8.7.5 Purdue Pharma Recent Developments
  43. 8.8 Sun Pharmaceutical Industries Ltd
  44. 8.8.1 Sun Pharmaceutical Industries Ltd Company Information
  45. 8.8.2 Sun Pharmaceutical Industries Ltd Business Overview
  46. 8.8.3 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
  49. 8.9 Pfizer Inc
  50. 8.9.1 Pfizer Inc Company Information
  51. 8.9.2 Pfizer Inc Business Overview
  52. 8.9.3 Pfizer Inc Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Inc Meperidine (Demerol) Product Portfolio
  54. 8.9.5 Pfizer Inc Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Meperidine (Demerol) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Meperidine (Demerol) Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meperidine (Demerol) Value Chain Analysis
  2. 9.1.1 Meperidine (Demerol) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meperidine (Demerol) Production Mode & Process
  6. 9.2 Meperidine (Demerol) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meperidine (Demerol) Distributors
  9. 9.2.3 Meperidine (Demerol) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst